Cambrex Appoints Tom Vadaketh as Executive Vice President and Chief Financial Officer
January 04, 2017 06:30 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule Active Pharmaceutical Ingredients (APIs), today announced the hiring...
Cambrex Reports Third Quarter 2016 Financial Results
November 04, 2016 07:00 ET
|
Cambrex Corporation
- Sales increased 8% in the quarter, full year sales and profit guidance increased - - Acquisition of North Carolina based PharmaCore completed - - Conference call at 8:30 a.m. ET on November 4,...
Cambrex to Announce Third Quarter 2016 Financial Results on November 4, 2016
November 01, 2016 13:34 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Bernhard Hampl Appointed to the Board of Directors of Cambrex Corporation
October 31, 2016 06:45 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Completes Acquisition of PharmaCore, Inc.
October 07, 2016 10:35 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 07, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Opens New Pilot Plant at Its Milan, Italy Site
October 03, 2016 03:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities
September 26, 2016 06:45 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Announces Investment and Expansion to Large Scale, Multi-Purpose Manufacturing Capabilities at its Karlskoga, Sweden, Facility
September 06, 2016 10:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at Upcoming Investor Conferences in September
August 26, 2016 09:40 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 26, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Reports Second Quarter 2016 Financial Results
July 28, 2016 07:00 ET
|
Cambrex Corporation
- Sales increased 12% for the quarter and full year sales and profit guidance increased - - New $50 million production facility in Iowa completed and in operation - - Conference call at 8:30 a.m....